Syneron's Home-Use Hair Removal Systems Receive Expanded Indication
12/19/2013
The FDA has granted Syneron Medical Ltd. and Iluminage Beauty an expanded indication for me™ brand of home-use hair removal systems. The systems, which utilize Syneron's proprietary elos technology, are now indicated for permanent reduction in hair growth. The me™ brand is owned and sold by Iluminage Beauty, Syneron's global joint venture in home beauty devices.
Shimon Eckhouse, Chief Executive Officer of Syneron Medical, said, "The additional indication for permanent reduction in hair growth for the me home-use hair removal system is another positive milestone in the application of our proprietary elos technology in the home-use market. It builds on its position as the first and only FDA cleared consumer hair removal technology that is approved for all skin tones, further differentiating it from the competition."
For more information on the me™ brand of home-use hair removal systems, please visit www.mePower.com.
Shimon Eckhouse, Chief Executive Officer of Syneron Medical, said, "The additional indication for permanent reduction in hair growth for the me home-use hair removal system is another positive milestone in the application of our proprietary elos technology in the home-use market. It builds on its position as the first and only FDA cleared consumer hair removal technology that is approved for all skin tones, further differentiating it from the competition."
For more information on the me™ brand of home-use hair removal systems, please visit www.mePower.com.